Seretide Diskus 50 mikrograma + 500 mikrograma u jednoj dozi, prašak inhalata, dozirani
| Name | Seretide Diskus 50 mikrograma + 500 mikrograma u jednoj dozi, prašak inhalata, dozirani |
|---|---|
| Marketing Authorisation Number | HR-H-251056275 |
| Active Substance | salmeterolksinafoat flutikazonpropionat |
| Composition | svaka pojedinačna inhalacija sadrži isporučenu dozu (iz nastavka za usta) od 47 mikrograma salmeterola (u obliku salmeterolksinafoata) 460 mikrograma flutikazonpropionata što odgovara predinhalacijskoj dozi od 50 mikrograma salmeterola (u obliku salmeterolksinafoata) i 500 mikrograma flutikazonpropionata |
| Pharmaceutical Form | prašak inhalata, dozirani |
| Manufacturer | Glaxo Wellcome Production, Evreux, Francuska |
| Marketing Authorisation Holder | GlaxoSmithKline Trading Services Limited, 12 Riverwalk, Citywest Business Campus, Dublin 24, Irska |
| Marketing Authorisation Date | 20.08.2021 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/19-02/78 |
| Registration Number | 381-12-01/70-21-16 |
| Prescription | na recept |
| Type of prescription | ponovljivi recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | R03AK06 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
